Supra-inguinal Fascia Iliaca Compartment Block on Postoperative Management in Total Hip Arthroplasty by Posterior Approach

Phase 4

Completed

• Conditions: Arthropathy of Hip
• Interventions: Procedure: Supra-inguinal fascia iliaca compartment block; Drug: Multimodal analgesia and PCA morphine pump

• Registration Number: NCT04574479
• Lead Sponsor: University of Liege

Brief Summary

Find the impact of supra-inguinal fascia iliaca compartment block on postoperative pain management after total hip arthroplasty by posterior surgical approach

Detailed Description

ASA physical status 1, 2 and 3 patients scheduled to undergo elective surgery of total hip arthroplasty under spinal anesthesia.

The investigators would like to study the impact of supra-inguinal fascia iliaca block on postoperative pain management after total hip arthroplasty by posterior surgical approach. The principal investigator perform this block with ultrasound technique. The investigators also want to observe if this loco-regional new approach to fascia iliaca block could have influence on opioid side effects, postoperative nausea and vomiting, length of hospitalisation and first mobilisation side effects.

Study Timeline

• Study First Submitted: 2020-08-31
• Study First Submitted QC: 2020-10-01
• Study First Posted: 2020-10-05
• Study Start: 2020-12-16
• Primary Completion: 2021-09-01
• Study Completion: 2021-09-02
• Status Verified: 2022-05
• Last Update Submitted: 2022-05-16
• Last Update Posted: 2022-05-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 86

Inclusion Criteria

• Adults patients scheduled to undergo elective surgery of total hip arthroplasty by posterior surgical aboard

Exclusion Criteria

• Patient refusal
• Allergy to used medications or local infection.
• Pregnancy
• Obesity with body mass index > 35
• History of chronic pain or fibromyalgia
• Drug (opioids) addiction
• Treatment with corticosteroids for more than 6 months
• Severe kidney or liver diseases
• Mental disorders or serious neurological diseases

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Fascia iliaca block	Multimodal analgesia and PCA morphine pump	Patients in this arm have multimodal analgesia with supra-inguinal fascia iliaca compartment block before surgery
Fascia iliaca block	Supra-inguinal fascia iliaca compartment block	Patients in this arm have multimodal analgesia with supra-inguinal fascia iliaca compartment block before surgery
Placebo	Multimodal analgesia and PCA morphine pump	Placebo group: patients have multimodal analgesia without fascia-iliaca compartment block

Primary Outcome Measures

Name	Time	Method
Opioid sparing	48 hours after the intervention	Difference in cumulated morphine consumption in the first 48 hours after surgery

Secondary Outcome Measures

Name	Time	Method
Opioid secondaries effects	48 hours after the intervention	incidence of secondary effects related to morphine consumption
Pain management satisfaction: questionnaire	48 hours after the intervention	pain management satisfaction score by IPO (International Pain Outcomes) questionnaire

Trial Locations

Locations (1)

CHU de Liège; 🇧🇪 Liège, Belgium